Back to Search Start Over

Definition of epitopes and antigens recognized by vaccinia specific immune responses: Their conservation in variola virus sequences, and use as a model system to study complex pathogens

Authors :
Sette, Alessandro
Grey, Howard
Oseroff, Carla
Peters, Bjoern
Moutaftsi, Magdalini
Crotty, Shane
Assarsson, Erika
Greenbaum, Jay
Kim, Yohan
Kolla, Ravi
Tscharke, David
Koelle, David
Johnson, R. Paul
Blum, Janice
Head, Steven
Sidney, John
Source :
Vaccine. Dec2009 Supplement 6, Vol. 27 Issue s, pG21-G26. 0p.
Publication Year :
2009

Abstract

Abstract: In the last few years, a wealth of information has become available relating to the targets of vaccinia virus (VACV)-specific CD4+ T cell, CD8+ T cell and antibody responses. Due to the large size of its genome, encoding more than 200 different proteins, VACV represents a useful model system to study immunity to complex pathogens. Our data demonstrate that both cellular and humoral responses target a large number of antigens and epitopes. This broad spectrum of targets is detected in both mice and humans. CD4+ T cell responses target late and structural antigens, while CD8+ T cells preferentially recognize early antigens. While both CD4+ and CD8+ T cell responses target different types of antigens, the antigens recognized by TH cells are highly correlated with those recognized by antibody responses. We further show that protein abundance and antibody recognition can be used to predict antigens recognized by CD4+ T cell responses, while early expression at the mRNA level predicts antigens targeted by CD8+ T cells. Finally, we find that the vast majority of VACV epitopes are conserved in variola virus (VARV), thus suggesting that the epitopes defined herein also have relevance for the efficacy of VACV as a smallpox vaccine. [Copyright &y& Elsevier]

Details

Language :
English
ISSN :
0264410X
Volume :
27
Issue :
s
Database :
Academic Search Index
Journal :
Vaccine
Publication Type :
Academic Journal
Accession number :
46764646
Full Text :
https://doi.org/10.1016/j.vaccine.2009.10.011